Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Jersey Health Reporter.
Press releases published on July 22, 2025
RefillGenie Provides Critical Medication Access as Millions Face Medicaid Coverage Loss
EIN Presswire
·
July 22, 2025
Telehealth platform offers affordable medication refills to address the healthcare access crisis affecting millions losing Medicaid benefits. JERSEY CITY, NJ, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- As millions of Americans prepare to lose …
XORTX Completes Non-Brokered Private Placement of Units
GlobeNewswire
·
July 22, 2025
Not For Distribution to United States News Wire Services or for Dissemination in the United States CALGARY, Alberta, July 22, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late- …
Pennant Announces Second Quarter 2025 Earnings Release and Call
GlobeNewswire
·
July 22, 2025
EAGLE, Idaho, July 22, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it expects to issue its second quarter …
Heartflow Plaque Analysis to be Covered by UnitedHealthcare Plans Nationwide
GlobeNewswire
·
July 22, 2025
MOUNTAIN VIEW, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced Heartflow Plaque Analysis will be covered by UnitedHealthcare across all lines of business, including …
Eupraxia Pharmaceuticals Invited to Present at Upcoming Investor Conferences
GlobeNewswire
·
July 22, 2025
VICTORIA, British Columbia, July 22, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology designed to …
Supernus Pharmaceuticals to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 5, 2025
GlobeNewswire
·
July 22, 2025
ROCKVILLE, Md., July 22, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that …
DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer
GlobeNewswire
·
July 22, 2025
Châtillon, France, July 22, 2025 DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), a clinical-stage biopharmaceutical company, today …
DBV Technologies annonce la nomination de James Briggs au poste de Directeur des Ressources Humaines
GlobeNewswire
·
July 22, 2025
Châtillon, France, le 22 juillet (22 :30 CEST) 2025 DBV Technologies annonce la nomination de James Briggs au poste de Directeur des Ressources Humaines DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT— CUSIP: 23306J309), …
STERIS to Host a Conference Call for Fiscal 2026 First Quarter Results on August 7, 2025
GlobeNewswire
·
July 22, 2025
DUBLIN, IRELAND, July 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2026 first quarter results at 9:00 a.m. ET on August 7, 2025. The conference …
Seer to Report Second Quarter 2025 Financial Results on August 6, 2025
GlobeNewswire
·
July 22, 2025
REDWOOD CITY, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the second quarter 2025 on Wednesday, August …
Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis
GlobeNewswire
·
July 22, 2025
Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis 50 mg once-daily dose of obefazimod led to a …
Amwell® to report second quarter 2025 operating results; company leaders to attend upcoming investor conferences
GlobeNewswire
·
July 22, 2025
BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report second quarter 2025 operating results after stock market trading hours on …
OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 5, 2025
GlobeNewswire
·
July 22, 2025
WARSAW, Ind., July 22, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to …
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025
GlobeNewswire
·
July 22, 2025
CANTON, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …
Sanuwave Health to Present at Canaccord Genuity Growth Conference
GlobeNewswire
·
July 22, 2025
EDEN PRAIRIE, Minn., July 22, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (NASDAQ: SNWV), a leading provider of next-generation, FDA-approved wound care products , today announced, that Morgan Frank, Chief Executive Officer, will present at the 45th …
Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025
GlobeNewswire
·
July 22, 2025
SUNNYVALE, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that it …
Jushi Holdings Inc. to Report Second Quarter 2025 Financial Results on August 5, 2025
GlobeNewswire
·
July 22, 2025
BOCA RATON, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the second …
Axogen, Inc. to report 2025 second quarter financial results on August 5, 2025
GlobeNewswire
·
July 22, 2025
ALACHUA, Fla. and TAMPA, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that it will report …
Intuitive Announces Second Quarter Earnings
GlobeNewswire
·
July 22, 2025
SUNNYVALE, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended June …
electroCore to Participate in Upcoming Investor Conferences
GlobeNewswire
·
July 22, 2025
ROCKAWAY, N.J., July 22, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the following investor conferences. Needham 10th Annual …